Feasibility and Safety of Repeat Instant Endovascular Interventions in Patients with Refractory Cerebral Vasospasms
- PMID: 27979797
- PMCID: PMC7959985
- DOI: 10.3174/ajnr.A5024
Feasibility and Safety of Repeat Instant Endovascular Interventions in Patients with Refractory Cerebral Vasospasms
Abstract
Background and purpose: For patients with cerebral vasospasm refractory to medical and hemodynamic therapies, endovascular therapies often remain the last resort. Data from studies in large cohorts on the efficacy and safety of multiple immediate endovascular interventions are sparse. Our aim was to assess the feasibility and safety of multiple repeat instant endovascular interventions in patients with cerebral vasospasm refractory to medical, hemodynamic, and initial endovascular interventions.
Materials and methods: This was a single-center retrospective study of prospectively collected data on patients with cerebral vasospasm refractory to therapies requiring ≥3 endovascular interventions during the course of treatment following aneurysmal subarachnoid hemorrhage. The primary end point was functional outcome at last follow-up (mRS ≤2). The secondary end point was angiographic response to endovascular therapies and the appearance of cerebral infarctions.
Results: During a 4-year period, 365 patients with aneurysmal subarachnoid hemorrhage were treated at our institution. Thirty-one (8.5%) met the inclusion criteria. In 52 (14%) patients, ≤2 endovascular interventions were performed as rescue therapy for refractory cerebral vasospasm. At last follow-up, a good outcome was noted in 18 (58%) patients with ≥3 interventions compared with 31 (61%) of those with ≤2 interventions (P = .82). The initial Hunt and Hess score of ≤2 was a significant independent predictor of good outcome (OR, 4.7; 95% CI, 1.2-18.5; P = .03), whereas infarcts in eloquent brain areas were significantly associated with a poor outcome (mRS 3-6; OR, 13.5; 95% CI, 2.3-81.2; P = .004).
Conclusions: Repeat instant endovascular intervention is an aggressive but feasible last resort treatment strategy with a favorable outcome in two-thirds of patients with refractory cerebral vasospasm and in whom endovascular treatment has already been initiated.
© 2017 by American Journal of Neuroradiology.
Conflict of interest statement
The authors declare no conflict of interest. This study was approved by the Ethics Committee of the Canton of Bern, Switzerland (Kantonale Ethikkommission Bern, KEK, 177/14).
Figures
 
              
              
              
              
                
                
                Comment in
- 
  
  Endovascular Rescue Therapy for Refractory Vasospasm: When and How?AJNR Am J Neuroradiol. 2017 Mar;38(3):568-569. doi: 10.3174/ajnr.A5082. Epub 2017 Jan 12. AJNR Am J Neuroradiol. 2017. PMID: 28082262 Free PMC article. No abstract available.
References
MeSH terms
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Miscellaneous
 
        